109 results
Page 4 of 6
424B5
vlo qt6lwy08s
22 Jan 21
Prospectus supplement for primary offering
5:27pm
8-K
EX-99.1
qoe58nph
5 Jan 21
Other Events
8:05am
8-K
EX-10.1
ziywcz0k0oc1vdkhl
18 Dec 20
Entry into a Material Definitive Agreement
7:00am
424B5
72flf pui7mi
17 Dec 20
Prospectus supplement for primary offering
9:54pm
8-K
EX-10.1
k4l jqf89uj
24 Nov 20
Entry into a Material Definitive Agreement
6:07am
424B5
79j5p7k2fksx7j
24 Nov 20
Prospectus supplement for primary offering
12:00am
8-K
EX-99.1
xs5glu0bqkky3 m58
19 Nov 20
Other Events
4:58pm
8-K
EX-99.2
cm5hlhz kucxyntk8
9 Nov 20
Baudax Bio Reports Third Quarter 2020 Financial Results
7:10am
8-K
EX-99.1
a4w9 oag2ocj7
9 Nov 20
Baudax Bio Reports Third Quarter 2020 Financial Results
7:10am
8-K
EX-99.1
04vs9ex mnz
20 Oct 20
Baudax Bio Provides Commercial and Corporate Update
7:30am
8-K
EX-99.1
o0cl15rewbdqxg s22o
22 Sep 20
Other Events
7:00am
8-K
EX-99.1
rm4xg5wn3m
10 Aug 20
Baudax Bio Reports Second Quarter 2020 Financial Results
7:01am
8-K
EX-99.2
roq9 f45909iu3h4ium
10 Aug 20
Baudax Bio Reports Second Quarter 2020 Financial Results
7:01am
8-K
EX-99.1
fdsphcrd4y0939uxxy
6 Aug 20
Baudax Bio Secures Permanent J-Code (J1738) for ANJESO® from
7:15am
8-K
EX-99.1
iqw970 n7mmrdx9raj6
31 Jul 20
Baudax Bio Announces Presentation of New Phase IIIb ANJESO® Data at the American Society of Colon and Rectal Surgeons 2020 Annual Scientific Meeting
8:41am
8-K
EX-99.1
eddrxcam7moc a4
20 Jul 20
Other Events
7:40am
8-K
EX-99.1
977h9r0o8rft
15 Jun 20
Baudax Bio Announces Full Commercial Launch of ANJESO™ and Receipt of UniqueC-Code and Pass-Through Payment Status
8:37am